Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Growth Stocks Trading in Oversold Territory

In this article, we will list the 5 Best Growth Stocks Trading in Oversold Territory. Please visit 12 Best Growth Stocks Trading in Oversold Territory to see the extended list and the methodology behind it.

5. Howmet Aerospace Inc. (NYSE:HWM)

Number of Hedge Fund Holders: 75

Howmet Aerospace Inc. (NYSE:HWM) is one of the best growth stocks trading in oversold territory. On May 7, Howmet Aerospace reported a strong start to 2026, with Q1 revenue increasing 19% year-over-year to $2.31 billion, surpassing the high end of its guidance. The company achieved an adjusted EBITDA margin of 32.0%, an improvement of 320 basis points, and reported an adjusted EPS of $1.22, a 42% increase from the prior year.

The company’s quarterly performance was supported by record cash generation, with $359 million in free cash flow, which supported $300 million in common stock repurchases. Strategic portfolio shifts also marked the period, including the acquisition of Consolidated Aerospace Manufacturing/CAM and the divestiture of a disk forging facility in Savannah, GA, aligning with the company’s focus on businesses with higher growth and margin potential.

Looking ahead, Howmet Aerospace Inc. (NYSE:HWM) has increased its full-year 2026 guidance, citing a robust growth outlook in commercial aerospace, defense, and gas turbine markets. While management remains cautious regarding demand in commercial transportation, they anticipate continued strength in engine spares and increased production rates from aerospace OEM customers, with the newly acquired assets expected to contribute to future growth.

Howmet Aerospace Inc. (NYSE:HWM) provides advanced engineered solutions for the aerospace and transportation industries. The company’s primary business focus is on providing components for aircraft engines, airframe structures, and fastening systems.

4. TransDigm Group Inc. (NYSE:TDG)

Number of Hedge Fund Holders: 87

TransDigm Group Inc. (NYSE:TDG) is one of the best growth stocks trading in oversold territory. On May 5, TransDigm Group reported strong Q2 2026, with net sales rising 18% year-over-year to $2.54 billion. The company achieved a net income of $536 million, a 12% increase, while EBITDA As Defined grew by 15% to $1.34 billion, maintaining a robust 52.6% margin. Adjusted EPS rose to $9.85, reflecting an 8% improvement over the prior year.

The company’s growth was driven by double-digit performance across all three major market channels, with the commercial aftermarket, led by a 16% increase in the commercial transport segment, showing particularly strong results. Following the quarter, TransDigm completed the $2.2 billion acquisition of Jet Parts Engineering and Victor Sierra to bolster its aftermarket presence and continued its capital return strategy by repurchasing $800 million in shares during the quarter and early April.

Management noted that core business margins improved when adjusting for acquisition dilution, and they remain committed to their value-driven operating strategy. Given the strong performance, TransDigm Group Inc. (NYSE:TDG) issued an upward revision to its FY2026 financial guidance and continues to pursue strategic expansion, including the pending acquisition of Stellant Systems.

TransDigm Group Inc. (NYSE:TDG) manufactures engineered aircraft components for commercial and military aircraft.

3. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 132

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks trading in oversold territory. On June 9, the US FDA approved a new maintenance dosing regimen for Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), allowing adults and children aged 12 and older with moderate-to-severe atopic dermatitis to receive a single injection once every 8 weeks. This approval makes EBGLYSS the only treatment option that can be managed with as few as six maintenance injections per year without the requirement of concomitant prescription topicals.

This dosing update is based on longitudinal exposure-response modeling and data from the Phase 3 ADjoin long-term extension trial. In the 32-week extension study, the drug showed durable disease control without any new safety signals or patient discontinuations due to adverse events, further establishing its clinical profile for long-term use.

Management noted that this regimen provides significant flexibility for patients, aiming to reduce the burden of daily symptom management and frequent injections. The most commonly reported side effects remain consistent with the existing profile, including conjunctivitis, injection site reactions, and herpes zoster.

Eli Lilly and Company (NYSE:LLY) is a healthcare company that develops human pharmaceutical products, including cardiometabolic health, oncology, and immunology products.

2. Advanced Micro Devices Inc. (NASDAQ:AMD)

Number of Hedge Fund Holders: 134

Advanced Micro Devices Inc. (NASDAQ:AMD) is one of the best growth stocks trading in oversold territory. On June 3, OQC, JPMorganChase, and AMD announced a research collaboration to develop a dedicated Quantum-AI platform at a new data center in London. The initiative will integrate OQC’s GENESIS quantum system with AMD’s HPC and AI infrastructure. JPMorganChase will serve as the first enterprise user, utilizing the secure environment to test hybrid quantum-classical workflows for complex financial challenges.

The partners will focus on research areas including portfolio optimization, quantum machine learning, and the development of specialized AI models to enhance quantum circuit performance. By physically integrating quantum hardware into a secure enterprise framework, the platform aims to enable the testing of algorithms for performance, scalability, and reproducibility, moving quantum research toward practical, real-world financial applications.

Expected to be fully operational within 12 months, the project represents a significant move from isolated quantum experimentation to integrated, enterprise-grade infrastructure. Executives from the three companies emphasized that the collaboration is designed to accelerate the discovery of purpose-built financial algorithms and show how quantum computing, AI, and classical computing can function together to address industry-specific needs.

Advanced Micro Devices Inc. (NASDAQ:AMD) is a leading semiconductor company specializing in HPC and graphics solutions. Its broad product portfolio includes microprocessors, graphics processors, and system-on-chip/SoC solutions designed for data centers, gaming, and embedded systems.

1. NVIDIA Corporation (NASDAQ:NVDA)

Number of Hedge Fund Holders: 275

NVIDIA Corporation (NASDAQ:NVDA) is one of the best growth stocks trading in oversold territory. On June 10, Google DeepMind released DiffusionGemma, an experimental open-weight model that uses NVIDIA hardware to achieve breakthrough text generation speeds. By abandoning the traditional token-by-token autoregressive approach in favor of parallel block generation, the model shifts the processing bottleneck from memory bandwidth to compute, allowing NVIDIA’s Tensor Cores to process up to 256 tokens simultaneously.

This parallel architecture is specifically optimized for the NVIDIA ecosystem, including GeForce RTX GPUs, the NVIDIA RTX PRO platform, and DGX Spark systems. Through the synergy between Google’s diffusion head and NVIDIA’s CUDA software stack, the model achieves performance gains of up to 4x over equivalent autoregressive models, hitting speeds of 2,000 tokens per second on NVIDIA DGX Station and 1,000 tokens per second on an H100 GPU.

By enabling this compute-heavy, low-latency performance, NVIDIA Corporation (NASDAQ:NVDA) makes advanced, local-first AI generation accessible to developers and researchers without the need for cloud-based inference. With day-zero support across key tools like Hugging Face, vLLM, and the NVIDIA NeMo framework, users can immediately deploy DiffusionGemma for rapid iteration, agentic loops, and interactive workflows on their own hardware.

NVIDIA Corporation (NASDAQ:NVDA) is a fabless semiconductor and AI computing company that designs GPUs, AI accelerators, Application Programming Interfaces/APIs, and system-on-a-chip units. Through its CUDA ecosystem, the company enables industries ranging from autonomous vehicles to scientific research by advancing AI, accelerated computing, and data center infrastructure.

While we acknowledge the potential of NVDA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVDA and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Most Profitable Growth Stocks to Buy and 8 Best Quality Growth Stocks to Buy.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.